Synaptogenix Other Current Liab from 2010 to 2024

SNPX Stock  USD 2.88  0.02  0.69%   
Synaptogenix Other Current Liabilities yearly trend continues to be fairly stable with very little volatility. Other Current Liabilities is likely to outpace its year average in 2024. During the period from 2010 to 2024, Synaptogenix Other Current Liabilities regression line of annual values had r-squared of  0.46 and arithmetic mean of  681,212. View All Fundamentals
 
Other Current Liabilities  
First Reported
2010-12-31
Previous Quarter
3.8 M
Current Value
M
Quarterly Volatility
1.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Synaptogenix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Synaptogenix's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.6 M or Interest Income of 1.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.21 or PTB Ratio of 0.12. Synaptogenix financial statements analysis is a perfect complement when working with Synaptogenix Valuation or Volatility modules.
  
Check out the analysis of Synaptogenix Correlation against competitors.
For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.

Latest Synaptogenix's Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Synaptogenix over the last few years. It is Synaptogenix's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Synaptogenix's overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Synaptogenix Other Current Liab Regression Statistics

Arithmetic Mean681,212
Geometric Mean173,441
Coefficient Of Variation196.13
Mean Deviation868,005
Median65,975
Standard Deviation1,336,076
Sample Variance1.8T
Range4M
R-Value0.68
Mean Square Error1T
R-Squared0.46
Significance0.01
Slope202,210
Total Sum of Squares25T

Synaptogenix Other Current Liab History

2024M
20233.8 M
2022652.6 K
2021698.4 K
2020352.2 K

About Synaptogenix Financial Statements

Synaptogenix investors use historical fundamental indicators, such as Synaptogenix's Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Synaptogenix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Liabilities3.8 MM

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Synaptogenix Stock Analysis

When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.